TMCnet News
Practice Fusion Presents Results of Real World Evidence (RWE) Study on Treatments of Type 2 Diabetes at EASD Annual MeetingSAN FRANCISCO, Oct. 18, 2016 /PRNewswire/ -- Practice Fusion, the nation's largest cloud-based connected health platform,1 announced new findings from a real-world evidence (RWE) study presented at the European Association for the Study of Diabetes (EASD) in Munich, Germany. The study, "A Cloud-Based Electronic Health Records Study of Treatment Intensification Patterns in Patients with Type 2 Diabetes Uncontrolled on = 2 Oral Antidiabetic Drugs," examined clinical practice and management patterns associated with timely intensification of treatment regimens in patients with type 2 diabetes (T2D) across multiple ambulatory care settings. The retrospective observational analysis used de-identified data from Practice Fusion's de-identified clinical database of more than 38 million records, representing 6.7 percent of all practices across the United States.2 With a cohort of 25,365 de-identified records, researchers compared the care given by independent practice providers to patients in need of intensifying their antidiabetic therapy for managing T2D versus the care from practitioners in different care settings (as reported in other studies). The study showed that providers in independent practices offer similar care to these patients. The results also demonstrate that when treating patients in need of intensifying their antidiabetic therapy to manage their T2D:
The RWE study abstract can be viewed online by accessing the EASD 52nd annual meeting program here. For more information about Practice Fusion's RWE solutions, please visit us online: http://www.practicefusion.com/life-sciences/. About Type 2 Diabetes (T2D) Timely intensification of anti-diabetes treatment in patients with T2D is beneficial in terms of reducing diabetic complications, and is supported by international guidelines.3,4 Although several clinical trials have evaluated the efficacy of treatment intensification in patients with uncontrolled T2D,5,6 there is limited information on real world clinical practice patterns associated with timely treatment intensification in patients with T2D. About Practice Fusion Media Contact: Research Contact: 1,2 SK&A, Report on Physician Office Usage of Electronic Healthcare Records Software (February 2016). http://www.skainfo.com/reports/physician-ehr-software-usage Logo - http://photos.prnewswire.com/prnh/20091118/PFLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/practice-fusion-presents-results-of-real-world-evidence-rwe-study-on-treatments-of-type-2-diabetes-at-easd-annual-meeting-300346162.html SOURCE Practice Fusion |